Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,384 | -12,582 | -27,075 | -16,360 | -21,461 |
| Depreciation Amortization | 262 | 150 | 750 | 596 | 413 |
| Accounts payable and accrued liabilities | 89 | -607 | 488 | -12 | 243 |
| Other Working Capital | -1,728 | -2,347 | 5,230 | 5,545 | 1,391 |
| Other Operating Activity | 1,481 | 1,463 | -16,502 | -16,813 | 970 |
| Operating Cash Flow | $-25,280 | $-13,923 | $-37,109 | $-27,044 | $-18,444 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,655 | 1,960 | 2,650 | 2,140 | 2,085 |
| PPE Investments | -32 | -29 | 18,755 | -125 | -86 |
| Investing Cash Flow | $4,623 | $1,931 | $21,405 | $2,015 | $1,999 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4 | -2 | -82 | -67 | -44 |
| Common Stock Issued | 869 | 86 | 85 | 82 | 63 |
| Financing Cash Flow | $865 | $84 | $3 | $15 | $19 |
| Beginning Cash Position | 48,044 | 48,044 | 63,745 | 63,745 | 63,745 |
| End Cash Position | 28,252 | 36,136 | 48,044 | 38,731 | 47,319 |
| Net Cash Flow | $-19,792 | $-11,908 | $-15,701 | $-25,014 | $-16,426 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,280 | -13,923 | -37,109 | -27,044 | -18,444 |
| Capital Expenditure | -32 | -29 | -142 | -125 | -86 |
| Free Cash Flow | -25,312 | -13,952 | -37,251 | -27,169 | -18,530 |